News
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
13h
Investor's Business Daily on MSNBioNTech ADR Meets 80-Plus Relative Strength Rating Benchmark
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...
Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...
Province will be the only one in Canada to charge most residents for COVID-19 vaccines during the 2025-26 respiratory virus ...
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...
Morning. Today, we examine the plush pay packages of health care’s top CEOs in 2024. Also, we discuss Stealth BioTherapeutics’ efforts to rally support behind its Barth syndrome drug, and hear more ...
The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?
Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to President Donald Trump, Robert F.
OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the appointment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results